CLINICAL_TRIALS
trial_result
· 2017-04-20
Clinical Trial Update: Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients [Phase 3]
Summary
A completed Phase 3 study evaluating FS 4 IU VH S/D (fibrin sealant with 4 IU/mL thrombin, vapor heated, solvent/detergent treated) to help adhere split-thickne…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxter Healthcare Corporation | Conditions: Deep Partial or Full Thickness Wounds | Phase 3 | Status: COMPLETED